• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

neovasc

Cleveland HeartLab pulls in $15M | Wall Street Beat

November 1, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Cleveland HeartLab pulled in $14.7 million in equity financing for its proprietary test for cardiac inflammation, according to a regulatory filing.

The CardioMPO test was developed by Dr. Stanley Hazen, director of the Cleveland Clinic’s center for cardiovascular diagnostics and prevention.

Cleveland HeartLab closed a $3 million round in 2010, with backers including Glengary and Second Generation Ltd.

Filed Under: Funding Roundup, News Well, Wall Street Beat Tagged With: 480 Biomedical, Arsenal Medical, Carestream Health Inc., Cleveland HeartLab LLC, conformis, Genesis Digital Imaging, LeMaitre Vascular Inc., neovasc, Oculeve

LeMaitre Vascular pays $5M for Neovasc’s XenoSure | Wall Street Beat

October 2, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

LeMaitre Vascular (NSDQ:LMAT) said it will pay $4.6 million for Neovasc‘s (NYSE:NVC) XenoSure vascular patch, used to repair blood vessels.

Filed Under: Mergers & Acquisitions, News Well, Wall Street Beat Tagged With: Boston Consulting Group, Cambridge Heart Inc., Corpak Medsystems Inc., LeMaitre Vascular Inc., Merck, neovasc

St. Jude Medical wins CE Mark, launches Enlightn renal denervation system | MassDevice.com On Call

May 15, 2012 By MassDevice staff Leave a Comment

MassDevice On Call

MASSDEVICE ON CALL —St. Jude Medical (NYSE:STJ) landed CE Mark approval and announced commercial launch for its Enlightn renal denervation system as a treatment for hypertension.

Filed Under: News Well Tagged With: Abbott, Boston Scientific, Capella Inc., Clinical Trials, InfraReDx Inc., neovasc, On Call, Renal, Stentys, stjudemedical, Svelte Medical Systems Inc., Volcano Corp.

Zimmer slides on Q1 results | Earnings Roundup

April 26, 2012 By MassDevice staff Leave a Comment

MassDevice.com Earnings Roundup

Investors sent shares of Zimmer (NYSE:ZMH) down 5% this morning in pre-market trading after the orthopedic device maker reported sales and earnings in-line with Wall Street’s expectations, but lackluster sales of hip and knee implants.

Filed Under: MassDevice Earnings Roundup, News Well, Orthopedics Tagged With: 2012, Arrhythmia Research Technology Inc., ConMed Corp., EnteroMedics Inc., Grifols, Hillrom, Hips, Invacare, Kelyniam Global Inc., Knees, Merit Medical Systems, Natus Medical Inc., neovasc, Neurometrix, Palomar Medical Technologies Inc., Q1, Rochester Medical Corp., RTI Surgical, Shire Plc., Sorin Group, Spectranetics Corp., Utah Medical, Varian Medical Systems, vascularsolutions, Young Innovations, Zimmer Biomet

Diabetes: Medtronic wins clearance for next-gen clinical continuous glucose monitor | Regulatory Roundup

November 25, 2011 By MassDevice staff Leave a Comment

Medtronic logo

Medtronic Inc. (NYSE:MDT) won FDA clearance for its next generation iPro2 Professional continuous glucose monitor.

The iPro2 Professional is a clinician-owned device that collects glucose data from a sensor inserted into a patient’s skin.

The device tracks the patient’s glucose levels for 3 days, collecting data as many as 288 times each day. The information may provide insight into how diet, medication and daily activities affect a patient’s glucose levels.

Filed Under: News Well Tagged With: BSD Medical Corp., Canon, CerMed International, Clinical Trials, Dendreon Corp., Fujifilm, IntriCon Corp., IsoRay, Merz, neovasc, Regulatory Roundup, Retina Implant AG, STAAR Surgical Co, Translational Sciences Corp., Vascular Designs Inc.

  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 6
  • Go to page 7
  • Go to page 8

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS